Profile

ScD, Harvard School of Public Health
MPH, University of Massachusetts Amherst

Pronouns: she/her/hers




Racial Differences in Splice Variants in Men with Localized Prostate Cancer
03/01/2018 - 01/30/2020 (PI)
Massachusetts General Hospital




Title

Patterns in long-term prescription opioid use in patients with cancer who are HIV-infected and HIV-uninfected
02/01/2019 - 01/31/2020 (PI)
BU/BMC

ACS Institutional Research Grant Pilot Award
02/01/2019 - 01/31/2020 (PI)
BU/BMC

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
BU SPH

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
BU SPH

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

Chronic Stress and Racial Disparities in Prostate Cancer
09/01/2013 - 08/31/2015 (PI)
Dana Farber/Harvard Cancer Center

Inflammation and Tissue Microenvironment as Predictors of Prostate Cancer Risk, Mortality and Therapy Response among Men with an Initially Benign TURP
08/01/2012 - 07/31/2014 (PI)
Dana Farber/Harvard Cancer Cente

Showing 10 of 11 results. Show All Results

Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Borno HT, Rider JR, Gunn CM. The Ethics of Delivering Precision Medicine-Pretest Counseling and Somatic Genomic Testing. JAMA Oncol. 2020 Jun 01; 6(6):815-816.View Related Profiles. PMID: 32163096
     
  2. Connors K, Flores-Torres MH, Stern D, Valdimarsdóttir U, Rider JR, Lopez-Ridaura R, Kirschbaum C, Cantú-Brito C, Catzin-Kuhlmann A, Rodriguez BL, Correa CP, Lajous M. Family Member Incarceration, Psychological Stress, and Subclinical Cardiovascular Disease in Mexican Women (2012-2016). Am J Public Health. 2020 01; 110(S1):S71-S77. PMID: 31967877
     
  3. Bernard B, Burnett C, Sweeney CJ, Rider JR, Sridhar SS. Impact of age at diagnosis of de novo metastatic prostate cancer on survival. Cancer. 2020 03 01; 126(5):986-993. PMID: 31769876
     
  4. Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, Stampfer MJ, Giovannucci E, Sweeney CJ, Finn SP, Mucci LA. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clin Cancer Res. 2020 03 01; 26(5):1086-1093. PMID: 31754047
     
  5. Rider JR, Trinquart L. Observational Studies Have a Critical Role to Play in Cancer Comparative Effectiveness Research. J Clin Oncol. 2019 10 10; 37(29):2695-2696.View Related Profiles. PMID: 31465256
     
  6. Lajous M, Cooperberg MR, Rider J, Manzanilla-García HA, Gabilondo-Navarro FB, Rodríguez-Covarrubias FT, López-Ridaura R, Torres-Sánchez LE, Mohar A. Prostate cancer screening in low- and middle-income countries: the Mexican case. Salud Publica Mex. 2019 Jul-Aug; 61(4):542-544. PMID: 31314214; DOI: 10.21149/10373;
     
  7. Kantor ED, Haneuse S, Valdimarsdóttir UA, Williams DR, Signorello LB, Rider JR. Socioenvironmental adversity and risk of prostate cancer in non-Hispanic black and white men. Cancer Causes Control. 2019 Sep; 30(9):997-1007. PMID: 31264140
     
  8. Trinquart L, Bill-Axelson A, Rider JR. Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies. Eur Urol. 2019 Aug; 76(2):137-139.View Related Profiles. PMID: 31031048
     
  9. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. PMID: 30165429
     
  10. Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):32-37. PMID: 30348512
     
Showing 10 of 99 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2017

YearPublications
20171

I am interested in mentoring graduate students and clinicians with an interest in cancer disparities, cancer prevention, or prognostic/predictive biomarkers.

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')